111 related articles for article (PubMed ID: 22275394)
1. Evaluation of the coagulation profile among oral and vaginal combined hormonal contraceptive users using sonoclot coagulation analyzer.
Brandy KR; Meyer RM; Luo X; Rao GH; Datta YH; Divani AA
Clin Appl Thromb Hemost; 2012 Nov; 18(6):576-81. PubMed ID: 22275394
[TBL] [Abstract][Full Text] [Related]
2. Oral versus vaginal combined hormonal contraceptives' effect on coagulation and inflammatory biomarkers among young adult women.
Divani AA; Luo X; Brandy KR; Meyer RM; Joseph MS; Flaherty JD; Rao GH; Datta YH
Clin Appl Thromb Hemost; 2012 Sep; 18(5):487-94. PubMed ID: 22431858
[TBL] [Abstract][Full Text] [Related]
3. Contraception, venous thrombosis and biological plausability.
Rott H
Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
5. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of thrombosis related to hormone therapy.
Sandset PM; Høibraaten E; Eilertsen AL; Dahm A
Thromb Res; 2009; 123 Suppl 2():S70-3. PubMed ID: 19217481
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Ishak R; Loh Chooi Khim
Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
10. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
11. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
Roumen FJ
Contraception; 2007 Jun; 75(6):420-9. PubMed ID: 17519147
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
13. Coagulation studies in women on combination type of oral contraceptives.
Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR
J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923
[TBL] [Abstract][Full Text] [Related]
14. [Thromboembolic complications in the use of oral estrogen-gestagen contraceptives].
Smírová S; Chochola M; Varejka P; Aschermann M
Vnitr Lek; 2001 Jul; 47(7):460-4. PubMed ID: 11505717
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Hormones and Clot Formation.
Swanepoel AC; Visagie A; Pretorius E
Microsc Microanal; 2016 Aug; 22(4):878-86. PubMed ID: 27515365
[TBL] [Abstract][Full Text] [Related]
16. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
17. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
18. Coagulation studies in women using combination type of oral contraceptives.
Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
[TBL] [Abstract][Full Text] [Related]
19. Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure.
Swanepoel AC; Emmerson O; Pretorius E
Microsc Microanal; 2017 Jun; 23(3):607-617. PubMed ID: 28480839
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
